(¿Â¶óÀÎ)2022 Cherry Blossom IBD Education Meeting Á¦ 8ȸ °æÈñ´ëÇб³º´¿ø ¿°Áõ¼ºÀåÁúȯ¼¾ÅÍ ¿¬¼ö°Á : 2022-03-27±³À°ÀÏÀÚ : 2022-03-27
±³À°Àå¼Ò : °æÈñ´ëÇб³º´¿ø ¾Ïº´¿ø±¹Á¦È¸ÀÇ½Ç 6Ãþ
±³À°ÁÖÁ¦ :
(¿Â¶óÀÎ)2022 Cherry Blossom IBD Education Meeting Á¦ 8ȸ °æÈñ´ëÇб³º´¿ø ¿°Áõ¼ºÀåÁúȯ¼¾ÅÍ ¿¬¼ö°Á ÁÖÃÖ±â°ü : °æÈñ´ëÇб³º´¿ø
´ã´çÀÚ : Á¶¹Ì¿µ
¿¬¶ôó : 02-958-8199
À̸ÞÀÏ :
kmcim@naver.com ±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀοø : 400¸í
Èñ¸ÁÆòÁ¡ : 3Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 3 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í linus204/asdf1122++
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 03-27 ¿Â¶óÀÎ 08:30~08:45 1. An Overview of The Natural History of IBD Â÷Àç¸í(°æÈñÀÇ´ë)
±³À°½Ã°£ 03-27 ¿Â¶óÀÎ 08:45~09:00 2. The ABCs of IBD Genetics ÀÌÈ£¼ö(¿ï»êÀÇ´ë)
±³À°½Ã°£ 03-27 ¿Â¶óÀÎ 09:00~09:15 3. Combined Assessment of Endoscopic and Histologic Activiy in UC ¹Ú¼ö°æ(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 03-27 ¿Â¶óÀÎ 09:15~09:30 4. Integration of Social media into daily practice of IBD °»ó¹ü(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 03-27 ¿Â¶óÀÎ 10:05~10:20 1. Optimizing First-line Anti-TNF Therapies for Maximal Benefit ¿¹º´´ö(¿ï»êÀÇ´ë)
±³À°½Ã°£ 03-27 ¿Â¶óÀÎ 10:20~10:35 2. How to Determine Second or Third Biologic Therapy Choice ¹®¿ø(°í½ÅÀÇ´ë)
±³À°½Ã°£ 03-27 ¿Â¶óÀÎ 10:35~10:50 3. Dual Targeted Therapy in Difficult-to-Treat Cases ¹Ú¼öÁ¤(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 03-27 ¿Â¶óÀÎ 10:50~11:05 4. Evidence Updates on Small molecules drugs °í¼ºÁØ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 03-27 ¿Â¶óÀÎ 11:40~11:55 1. Intestinal Ultrasound in Small Bowel CD – Pearls and Pitfalls ¹®¼º°æ(°æÈñÀÇ´ë)
±³À°½Ã°£ 03-27 ¿Â¶óÀÎ 11:55~12:10 2. Disease Flares during Pregnant patient with IBD (A Case-based Approach) ¼ÛÀº¹Ì(ÀÌÈÀÇ´ë)
±³À°½Ã°£ 03-27 ¿Â¶óÀÎ 12:10~12:25 3. Surgical Optimisation for Complicated CD ¹Ú¼±Áø(°æÈñÀÇ´ë)
±³À°½Ã°£ 03-27 ¿Â¶óÀÎ 12:25~12:40 4. IBD-related spondyloarthropathy (A Case-based Approach ) ¿À½ÅÁÖ(°æÈñÀÇ´ë)